Lil­ly to pay up to $660M in new deal with PRISM Bi­o­Lab; Boehringer part­ners with Phe­nom­ic AI

Plus, news about As­cendis Phar­ma, Bi­olex­is, Ape­ri­am Bio, Bio­mX and Ital­far­ma­co:

DEALS

Eli Lil­ly inks new deal with PRISM Bi­o­Lab: The In­di­anapo­lis Big Phar­ma is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER